The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, September 17, 2020
REYVOW for migraine had 3.8 and 4.6 times greater odds, respectively, of achieving pain freedom at 2 hours compared to those taking placebo.
read more
Friday, September 18, 2020
SpringWorks has entered into an agreement with Janssen to evaluate nirogacestat in combination with teclistamab for relapsed or refractory multiple ...
read more
Friday, September 18, 2020
Boehringer Ingelheim announced the results from a 12-week, placebo-controlled Phase II trial, that demonstrate BI 425809 met its primary endpoint.
read more
Friday, September 18, 2020
Fortress announced Caelum, in collaboration with Alexion, has initiated the CARES program to evaluate CAEL-101 in combination with standard-of-care (...
read more
Monday, September 21, 2020
BioNTech will receive a grant from the German Federal Ministry of Education and Research to support the accelerated development of SARS-CoV-2 vaccines...
read more
Monday, September 21, 2020
Immunity Pharma announced interim results from its Phase 1/2a clinical study with IPL344, an Akt activating disease-modifying drug for the treatment ...
read more
Tuesday, September 22, 2020
7 Hills Pharma has been awarded a two-year, $2 million SBIR grant from the NCI of the U.S. National Institutes of Health.
read more
Tuesday, September 22, 2020
Arena announced the first subject has been dosed in the global trial evaluating etrasimod as a potential treatment for ulcerative colitis.
read more
Tuesday, September 22, 2020
The Cura Foundation in collaboration with The Marcus Foundation is supporting a trial of hCT-MSC to treat children with Multisystem Inflammatory ...
read more
Wednesday, September 23, 2020
Rigel announced the start of a multicenter, Phase 2 trial to evaluate the safety of fostamatinib, its oral SYK inhibitor, for hospitalized COVID-19 ...
read more
Wednesday, September 23, 2020
BioNTech announced the signing of a share purchase agreement with Novartis AG, Basel / Switzerland to acquire their GMP certified manufacturing ...
read more
Wednesday, September 23, 2020
Menarini Ricerche announced the results of the dose escalation part of its B-PRECISE-01 MEN1611 trial, a potent and selective PI3K inhibitor in ...
read more
Wednesday, September 23, 2020
Johnson & Johnson announced the launch of its large-scale Phase 3 trial for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its ...
read more
Thursday, September 24, 2020
MorphoSys and I-Mab announced the FDA has cleared the IND for antibody MOR210/TJ210 for relapsed or refractory advanced solid tumors.
read more
Thursday, September 24, 2020
Acella is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid to the consumer level.
read more